Header Logo

Connection

LAURENCE MCCULLOUGH to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications LAURENCE MCCULLOUGH has written about Breast Neoplasms.
LAURENCE MCCULLOUGH
Connection Strength
5.752
Breast Neoplasms
  1. A registry-based approach for estimating county-level race disparities in breast cancer mortality: an analysis in Georgia. Am J Epidemiol. 2025 Sep 03; 194(9):2698-2704.
    View in: PubMed
    Score: 0.392
  2. Neighborhood Deprivation and Breast Cancer Mortality Among Black and White Women. JAMA Netw Open. 2024 06 03; 7(6):e2416499.
    View in: PubMed
    Score: 0.360
  3. Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia. Breast Cancer Res Treat. 2024 Jun; 205(3):609-618.
    View in: PubMed
    Score: 0.355
  4. Racial disparity in breast cancer survivorship: themes from a series of four national healthcare provider live virtual forums. J Cancer Surviv. 2023 08; 17(4):1008-1016.
    View in: PubMed
    Score: 0.332
  5. Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality. Cancer. 2022 09 15; 128(18):3370-3382.
    View in: PubMed
    Score: 0.316
  6. Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality. Ann Surg Oncol. 2022 Aug; 29(8):4728-4738.
    View in: PubMed
    Score: 0.310
  7. Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta. J Natl Compr Canc Netw. 2021 08 16; 19(11):1242-1251.
    View in: PubMed
    Score: 0.296
  8. Racial Disparities in Diagnostic Delay Among Women With Breast Cancer. J Am Coll Radiol. 2021 10; 18(10):1384-1393.
    View in: PubMed
    Score: 0.295
  9. Redlining, Lending Bias, and Breast Cancer Mortality-Reply. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):800.
    View in: PubMed
    Score: 0.289
  10. Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area. Cancer Epidemiol Biomarkers Prev. 2021 01; 30(1):53-60.
    View in: PubMed
    Score: 0.279
  11. Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer. Breast Cancer Res. 2020 06 17; 22(1):65.
    View in: PubMed
    Score: 0.273
  12. Obesity-associated methylation in breast tumors: a possible link to disparate outcomes? Breast Cancer Res Treat. 2020 May; 181(1):135-144.
    View in: PubMed
    Score: 0.269
  13. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. Int J Epidemiol. 2019 12 01; 48(6):1897-1905.
    View in: PubMed
    Score: 0.263
  14. Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes. Breast Cancer Res. 2017 02 21; 19(1):19.
    View in: PubMed
    Score: 0.217
  15. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. Breast Cancer Res Treat. 2016 Feb; 156(1):183-94.
    View in: PubMed
    Score: 0.203
  16. Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer. Ann Epidemiol. 2015 Apr; 25(4):263-9.
    View in: PubMed
    Score: 0.188
  17. Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study. Cancer Causes Control. 2026 Jan 21; 37(2):33.
    View in: PubMed
    Score: 0.101
  18. 17?-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. Breast Cancer Res. 2025 Dec 30; 28(1):28.
    View in: PubMed
    Score: 0.100
  19. The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design. Epidemiology. 2024 09 01; 35(5):660-666.
    View in: PubMed
    Score: 0.091
  20. Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors. Int J Cancer. 2024 Sep 15; 155(6):996-1006.
    View in: PubMed
    Score: 0.089
  21. Neighborhood Deprivation and DNA Methylation and Expression of Cancer Genes in Breast Tumors. JAMA Netw Open. 2023 11 01; 6(11):e2341651.
    View in: PubMed
    Score: 0.086
  22. Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2023 07 05; 32(7):963-975.
    View in: PubMed
    Score: 0.084
  23. Barriers to breast cancer screening in Atlanta, GA: results from the Pink Panel survey at faith-based institutions. Cancer Causes Control. 2022 Dec; 33(12):1465-1472.
    View in: PubMed
    Score: 0.080
  24. Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women. Clin Cancer Res. 2021 03 01; 27(5):1421-1428.
    View in: PubMed
    Score: 0.071
  25. 17?-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study. Acta Oncol. 2020 Mar; 59(3):329-333.
    View in: PubMed
    Score: 0.065
  26. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study. Cancer. 2019 11 01; 125(21):3836-3844.
    View in: PubMed
    Score: 0.064
  27. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women. J Womens Health (Larchmt). 2017 03; 26(3):294-302.
    View in: PubMed
    Score: 0.054
  28. Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change. Environ Res. 2017 Jan; 152:17-25.
    View in: PubMed
    Score: 0.053
  29. Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study. Cancer Causes Control. 2016 Mar; 27(3):403-14.
    View in: PubMed
    Score: 0.050
  30. Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer. Environ Res. 2016 Feb; 145:93-100.
    View in: PubMed
    Score: 0.050
  31. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study. Cancer Causes Control. 2015 Dec; 26(12):1791-802.
    View in: PubMed
    Score: 0.049
  32. Beyond Tuskegee: A contemporary qualitative assessment of barriers to research participation among Black women. Cancer. 2025 Jan 01; 131(1):e35648.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.